♢ At the end of a title indicates that the FDA has not cleared prescription drugs, approved medical devices and/or biologics for the use described in this presentation. The prescription drugs, approved medical devices and/or biologics are being discussed for an off-label use.

Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Name
      Event Title
        Event Type
          Category-Classification
            Event Day

              280 Increased Neoadjuvant Chemotherapy to Surgery Time Interval is Associated with Decreased Tumor Percent Necrosis in Osteosarcoma

              Author:Akhil Rekulapelli, BS  Stephen Chenard, MSc  Rachel Mersfelder, BA  Jessica Klein, BA  Hakmook Kang, PhD  Reena Singh, MD  Herbert Schwartz, MD,FAAOS  Scott Borinstein, MD, PhD  Joshua Lawrenz, MD, FAAOS  

              Event Title:(279-286) VIPER: Musculoskeletal Oncology II Papers  

              Event Type:Paper Presentations  

              Category-Classification:Musculoskeletal Oncology  

              Event Day:Tuesday, March 11  

              281 Decreased Tumor Percent Necrosis is Associated with Positive Final Margin Status in Osteosarcoma

              Author:Akhil Rekulapelli, BS  Stephen Chenard, MSc  Rachel Mersfelder, BA  Jessica Klein, BA  Hakmook Kang, PhD  Reena Singh, MD  Herbert Schwartz, MD,FAAOS  Scott Borinstein, MD, PhD  Joshua Lawrenz, MD, FAAOS  

              Event Title:(279-286) VIPER: Musculoskeletal Oncology II Papers  

              Event Type:Paper Presentations  

              Category-Classification:Musculoskeletal Oncology  

              Event Day:Tuesday, March 11  

              282 Orthopaedic Oncology Administrative Coding Data Submitted to the U.S. News & World Report: Accuracy and Implications

              Author:William B. Gilbert, MD  Herbert Schwartz, MD,FAAOS  Joshua Lawrenz, MD, FAAOS  Aleksander P. Mika, MD  Katherine Hajdu, BS  Stephen Chenard, MSc  Julia Quirion, MD  

              Event Title:(279-286) VIPER: Musculoskeletal Oncology II Papers  

              Event Type:Paper Presentations  

              Category-Classification:Musculoskeletal Oncology  

              Event Day:Tuesday, March 11  

              e359 Intraoperative Frozen Bone Marrow Margins During Long Bone Ewing Sarcoma Resection – More Trouble Than They’re Worth?

              Author:Stephen Chenard, MSc  Akhil Rekulapelli, BS  Rachel Mersfelder, BA  Hakmook Kang, PhD  Jennifer Halpern, MD, FAAOS  Herbert Schwartz, MD,FAAOS  Reena Singh, MD  Scott Borinstein, MD, PhD  Joshua Lawrenz, MD, FAAOS  

              Event Title:e356-e370 Musculoskeletal Oncology ePosters  

              Event Type:ePosters  

              Category-Classification:Musculoskeletal Oncology  

              Event Day:Monday, March 10